Ann: EML Signs Agreement with McMillan Shakespeare Ltd, page-25

It all seems to be chugging up nicely as I suggested above...only 76.5c to go to get to analyst's value ,after the destruction wrought by a couple of months of whale tail slapping,aided and abetted by shorters (the dramatic pullback from $2 to $1.91 in one move on the excellent MMS contract was "strange" to say the least-a helluva tail slap ,matched by the dumpster dive on 2nd Dec. ,another 10c drop in one move ,in round figures,which I think may have been a lucky hit of a stop loss or a very brave short sell indeed,I don't pretend to know).In typical fashion ,the market will catch on in the last 5-10c worth as it usually does imo and bemoan "why didn't I move earlier". The HY is approximately 30 days away ,when on my guesstimate value will rise again beyond $2.50 (it might take a few days--maybe a bit more- after the report,which should be a boomer , but that's way beyond where we are now ),but these are my opinions only and of course,as a holder my interests are in seeing the SP rise -- a better springboard for the mid-Feb. bounce.In the meantime,I have not been (and still am not) adverse to some great bargain buying....who can resist a good "special" ? and this price is still enormously cheap imo... I seem to have been fortunate in picking the turns so far.It helps to have a value ,not just a chart ,I guess ,but watching the chart has helped.... as it usually does.Oh, and in case I don't post again before the HY,be careful of using just NPAT.Because two huge acqusitions have been made (the UK ,then the US) ,GAAP accounting conventions require amortisation ,which in the case of EML is artificial (all the intangibles/goodwill it acquired will not be any less with use, more likely the reverse but they are required to write them down ) but it does artificially reduce NPAT (it is not in fact an "overhead"but is deducted like one).It reduced NPAT to 88k instead of the more accurate in the sense of not misleading EBITDA figure of $5.5m last June.....with that and leaving out the US acquisition,and not taking into account current earnings (the EBITDA was up 111% last June and that was before the huge U.S acquisition and its earnings and before 6 months of organic growth at the best earning time of the year elsewhere ) does anyone wonder why the applying of current price to old (June 2016) earnings produces an utterly misleading 3 figure P/E ,when automatic P/E calculators that large sites use ,blindly calculate ? Since that seems to have concerned some holders ,I thought I should comment.It's a lesson in reading up how to calculate your own P/E and understanding (REALLYunderstanding ) how the "earnings" part of the metric is calculated and how OLD it is.(P/E is not really suitable for fast growers ,it is for stable large companies with fairly regular earnings imo).The P/E problem and last year's NPAT has probably confused would-be buyers ,who have not looked beyond surface figures.
This I think/hope will be my last post as all seems to be on track now....and again all imo .Hope some comments helped.